Loading clinical trials...
Loading clinical trials...
The aim of our study is to evaluate the effect of coffee consumption on the risk of severe liver fibrosis in French patients with NASH.
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Versailles Hospital
NCT05463796 · Cancer Risk, Cancer Predisposition Syndrome, and more
NCT05821010 · Non Alcoholic Steatohepatitis, Non-Alcoholic Fatty Liver Disease, and more
NCT05574036 · Non Alcoholic Steatohepatitis, Hyperuricemia
NCT04052516 · Non Alcoholic Steatohepatitis (NASH)
NCT04065841 · Non Alcoholic Steatohepatitis (NASH)
Centre Hospitalier de Béziers
Béziers
Centre hospitalier Métropole Savoie
Chambéry
Centre Hospitalier Sud Francilien
Corbeil-Essonnes
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions